switch from semaglutide to tirzepatide washout Switching Switching from Semaglutide to Tirzepatide

Benefits Semaglutide has been FDA approved for type 2 diabetes (2017) and weight loss (2021)

It adds creaminess to meals without the nausea-triggering heaviness of butter or cheese

The treatment combines two anti-aging approaches: microneedling and radiofrequency energy emission

Tirzepatide belongs to a newer class of medications that support metabolic wellness by targeting two key hormone pathways: GLP-1 (Glucagon-Like Peptide-1): Helps regulate appetite and blood sugar GIP (Glucose-Dependent Insulinotropic Polypeptide): Plays a role in insulin response and fat metabolism This dual action is designed to help patients feel fuller for longer and support insulin function under medical supervision

On our model: At Rivas, the large majority of our GLP-1 patients use compounded semaglutide or compounded tirzepatide, drawn from vials and administered in-office by their provider at each visit